Stock listing

Frankfurt:BIX0 BioInvent International AB Aktie

German listing (Frankfurt) of BioInvent International AB · home listing Stockholm:BINV

Follow BioInvent International AB into a list and get an email when it puts out news.

Share price · FWB:BIX0

€1.80 EUR +0.02 (+1.4%)

Close on Oct 27, 2026

Day range
€1.80 – €1.80 EUROct 27, 2026
Market cap
€118.3M EURAt the close on Oct 27, 2026 · price × 65.80M shares outstanding
BioInvent International AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:BINV · Home20.80 SEK+0.30 (+1.5%)95,77420.6521.3020.2020.50Close on Oct 27, 2026
Frankfurt:BIX0€1.798 EUR+0.024 (+1.4%)—€1.798€1.798€1.798€1.774Close on Oct 27, 2026
Ticker
Frankfurt:BIX0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Bioinvent International (Stockholm:BINV) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:00 AM ET

    Watch Transcript
  • Bioinvent International (Stockholm:BINV) Q3 2025 Earnings Call

    Wed, Oct 29, 2025 · 9:00 AM ET

    Watch Transcript

Latest news

All BioInvent International AB news

Decks

BioInvent International AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 30 in all · newest Oct 18, 2026 · oldest 2025
Calls
2 calls with a replay · 2 with a transcript · latest Feb 26, 2026
Decks
12 decks · latest October 2026

Where BioInvent International AB is listed

ListingExchangeCountryCurrency
Stockholm:BINV · Home listingStockholmSwedenSEK
Aquis:BINVSAquisUnited KingdomSEK
Stuttgart:BIX0StuttgartGermanyEUR
LS Exchange:A2QJRWLS ExchangeGermanyEUR
Lang & Schwarz:A2QJRWLang & SchwarzGermanyEUR
gettex:BIX0gettexGermanyEUR
Frankfurt:BIX0 · This pageFrankfurtGermanyEUR
Dusseldorf:BIX0DusseldorfGermanyEUR
LSIN:0H22LSINUnited KingdomSEK
Munich:BIX0MunichGermanyEUR
OTC:BOVNFOTCUnited StatesUSD
Aquis:BINVSAquisUnited KingdomSEK
Turquoise:BINVSTurquoiseUnited KingdomSEK

Log in to ask 6ix AI your own questions about BioInvent International AB.